Zydus Lifesciences Ltd

29/01/2026

Zydus Lifesciences has launched Tishtha™, the world's first biosimilar version of the cancer immunotherapy drug nivolumab in India. This is a significant milestone for oncology treatment access in the country.

26/01/2026

26/01/2026

Wish you all Happy republic day.

26/01/2026

Happy republic day.

24/01/2026

Our Managing Director, Dr. Sharvil Patel took the stage to recognize the outstanding contributions of our teams, starting with the Best Brand and Best Plant awards for this year.

22/01/2026

Zydus launches the world’s first biosimilar of Nivolumab, ‘Tishtha™’, in India to treat multiple cancers.

13/01/2026

Sentynl Therapeutics Inc., a Zydus Group company, has received FDA approval for ZYCUBO® (copper histidinate). This approval establishes ZYCUBO® as the first and only therapy approved in the United States for the treatment of Menkes disease.

01/01/2026

Health is wealth

01/01/2026

May the year ahead bring peace, good health, happiness, and prosperity to all, and strengthen our collective resolve to build a stronger and developed India.

29/12/2025

Zydus Hospitals is honoured to be the official healthcare partner for the AFC U17 Asian Cup Saudi Arabia 2026 (Qualifiers), delivering round-the-clock medical support to athletes, staff, and visitors.

With dedicated emergency responders and on-ground medical units, our doctors, nurses, and paramedics worked seamlessly behind the scenes so the players could focus on what mattered most - the game.

Here's a glimpse of how our commitment to care plays out in action.

Cup

Partner

Healthcare Support

08/12/2025

Our Managing Director, Dr. Sharvil Patel, has been conferred the Businessperson of the Year Award 2024–25 (Big Company) at the prestigious BioSpectrum Excellence Awards.

Honouring the torchbearers of Indian bioscience and healthcare, the award was presented by Dr. Jitendra Singh, Minister of Science and Technology, Government of India.

The award recognises Zydus’ notable achievements, standout contributions, successful new product launches, and new partnerships over the past year.